Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Diabetes Research and Clinical Practice
|
February 12, 2000
No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy
M A Crook, S Khandhadia, P Lumb, et al.
Atherosclerosis
|
September 17, 1999
Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain
E B Wu, P Lumb, J B Chambers, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 24, 1998
Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia
A S Wierzbicki, P J Lumb, J Cheung, et al.
Circulation
|
January 25, 2000
Natural statins and stroke
A S Wierzbicki, M A Crook, D P Mikhailidis, et al.
Lancet (London, England)
|
August 15, 2001
Measurement of atherosclerosis progression
A S Wierzbicki, M A Crook, T M Reynolds, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 18, 2000
Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia
A S Wierzbicki, M Lambert-Hammill, P J Lumb, et al.
QJM : Monthly Journal of the Association of Physicians
|
July 17, 1998
High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia
A S Wierzbicki, P J Lumb, Y K Semra, et al.
Lancet (London, England)
|
March 11, 1998
Effect of atorvastatin on plasma fibrinogen
A S Wierzbicki, P J Lumb, Y K Semra, et al.
BMJ (Clinical Research Ed.)
|
July 4, 1998
People at risk of coronary heart disease should not be denied treatment with effective drugs for purely financial reasons
T M Reynolds, A S Wierzbicki, M A Crook, et al.
Diabetologia
|
June 1, 1994
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria
J C Pickup, G D Chusney, M A Crook, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Diabetes Research and Clinical Practice
|
February 12, 2000
No difference in serum sialic acid in type 2 diabetic patients from the United Arab Emirates with and without diabetic retinopathy
M A Crook, S Khandhadia, P Lumb, et al.
Atherosclerosis
|
September 17, 1999
Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain
E B Wu, P Lumb, J B Chambers, et al.
QJM : Monthly Journal of the Association of Physicians
|
January 24, 1998
Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia
A S Wierzbicki, P J Lumb, J Cheung, et al.
Circulation
|
January 25, 2000
Natural statins and stroke
A S Wierzbicki, M A Crook, D P Mikhailidis, et al.
Lancet (London, England)
|
August 15, 2001
Measurement of atherosclerosis progression
A S Wierzbicki, M A Crook, T M Reynolds, et al.
Hypertension (Dallas, Tex. : 1979)
|
November 18, 2000
Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia
A S Wierzbicki, M Lambert-Hammill, P J Lumb, et al.
QJM : Monthly Journal of the Association of Physicians
|
July 17, 1998
High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia
A S Wierzbicki, P J Lumb, Y K Semra, et al.
Lancet (London, England)
|
March 11, 1998
Effect of atorvastatin on plasma fibrinogen
A S Wierzbicki, P J Lumb, Y K Semra, et al.
BMJ (Clinical Research Ed.)
|
July 4, 1998
People at risk of coronary heart disease should not be denied treatment with effective drugs for purely financial reasons
T M Reynolds, A S Wierzbicki, M A Crook, et al.
Diabetologia
|
June 1, 1994
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria
J C Pickup, G D Chusney, M A Crook, et al.
Page
of 10